Ophthalmic Business News

Bausch + Lomb Corp. announced the launch of its initial public offering and roadshow for the IPO.

In this video, Gary W. Herschman, JD, discusses “second bite” transactions in the private equity realm in the health care marketplace.

In this video, Gary W. Herschman, JD, discusses when a physician group should consider entering into a strategic transaction with a private equity group and what changes should be expected.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Euan S. Thomson, PhD, president of ophthalmology at Zeiss, discusses the FDA clearance of the Quatera 700 phaco, vitrectomy and lens fragmentation system.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Emil Chynn, MD, MBA, discusses a recent trip he took delivering medical supplies to Ukraine.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Warren Foust, worldwide president of surgical vision for Johnson & Johnson Vision, discusses everything the company has happening at ASCRS.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Adam Szaronos, CEO of TearLab, discusses the intersection of ocular surface disease treatment and refractive cataract surgery.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Jim Mazzo, executive chairman of Neurotech Pharmaceuticals, discusses the importance of meetings such as Eyecelerator in the ophthalmology landscape.

In this video, Gary W. Herschman, JD, discusses how physicians can maximize their transaction value by practicing due diligence and getting their practice in order before considering a private equity transaction.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Tom Frinzi, executive chairman of ViaLase, discusses a product in clinical trials for the noninvasive treatment of open-angle glaucoma in a stand-alone procedure.